Literature DB >> 11024159

Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection.

S D Lawn1, S T Butera.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) bearing HLA-DR in its envelope was detected in plasma from all patients with chronic HIV-1 infection (n = 16) and was present at higher levels in patients with active tuberculosis coinfection (n = 6). Intriguingly, however, HLA-DR was not detectable in HIV-1 from patients during primary viremia (n = 6), suggesting the possibility of virus replication in less-activated cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024159      PMCID: PMC102069          DOI: 10.1128/jvi.74.21.10256-10259.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Host protein incorporation is conserved among diverse HIV-1 subtypes.

Authors:  B D Roberts; S T Butera
Journal:  AIDS       Date:  1999-02-25       Impact factor: 4.177

2.  Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix.

Authors:  S D Lawn; S Subbarao; T C Wright; T Evans-Strickfaden; T V Ellerbrock; J L Lennox; S T Butera; C E Hart
Journal:  J Infect Dis       Date:  2000-05-31       Impact factor: 5.226

3.  Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.

Authors:  S D Lawn; B D Roberts; G E Griffin; T M Folks; S T Butera
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Delays in the diagnosis of tuberculosis: a great new cost.

Authors:  S D Lawn; R J Shattock; G E Griffin
Journal:  Int J Tuberc Lung Dis       Date:  1997-10       Impact factor: 2.373

5.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

6.  Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans.

Authors:  S D Lawn; R J Shattock; J W Acheampong; R B Lal; T M Folks; G E Griffin; S T Butera
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

7.  Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively.

Authors:  S D Lawn; D Rudolph; S Wiktor; D Coulibaly; A Ackah; R B Lal
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

8.  Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection.

Authors:  J F Salazar-Gonzalez; O Martinez-Maza; P Nishanian; N Aziz; L P Shen; S Grosser; J Taylor; R Detels; J L Fahey
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

9.  Anti-class II antibodies in AIDS patients and AIDS-risk groups.

Authors:  S de la Barrera; L Fainboim; S Lugo; G R Picchio; G R Muchinik; M M de Bracco
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

10.  The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.

Authors:  M S Sulkowski; R E Chaisson; C L Karp; R D Moore; J B Margolick; T C Quinn
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  11 in total

1.  Nanoparticle-based flow virometry for the analysis of individual virions.

Authors:  Anush Arakelyan; Wendy Fitzgerald; Leonid Margolis; Jean-Charles Grivel
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

2.  Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.

Authors:  M T Esser; J W Bess; K Suryanarayana; E Chertova; D Marti; M Carrington; L O Arthur; J D Lifson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment.

Authors:  Michaël Imbeault; Michel Ouellet; Katia Giguère; Jonathan Bertin; Dave Bélanger; Geneviève Martin; Michel J Tremblay
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

4.  Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation.

Authors:  M T Esser; D R Graham; L V Coren; C M Trubey; J W Bess; L O Arthur; D E Ott; J D Lifson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 5.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Characterization of HIV-1 RNA forms in the plasma of patients undergoing successful HAART.

Authors:  Carlos A Lopez; Manuel Vazquez; Martin D Hill; Maria Del C Colon; Tirtsa Porrata-Doria; Ian C D Johnston; Eric Lorenzo
Journal:  Arch Virol       Date:  2010-04-23       Impact factor: 2.574

7.  The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.

Authors:  Corinne Barat; Geneviève Martin; Adrien R Beaudoin; Jean Sévigny; Michel J Tremblay
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

8.  Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV.

Authors:  David M Stevens; Pavan Adiseshaiah; Siva S K Dasa; Tim M Potter; Sarah L Skoczen; Kelsie S Snapp; Edward Cedrone; Nimit Patel; Kathleen Busman-Sahay; Elias P Rosen; Craig Sykes; Mackenzie Cottrell; Marina A Dobrovolskaia; Jacob D Estes; Angela D M Kashuba; Stephan T Stern
Journal:  Mol Pharm       Date:  2020-09-09       Impact factor: 4.939

9.  Virus-producing cells determine the host protein profiles of HIV-1 virion cores.

Authors:  Steven Santos; Yuri Obukhov; Sergei Nekhai; Michael Bukrinsky; Sergey Iordanskiy
Journal:  Retrovirology       Date:  2012-08-13       Impact factor: 4.602

Review 10.  Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents.

Authors:  Mayte Coiras; Emilio Camafeita; María Rosa López-Huertas; Enrique Calvo; Juan Antonio López; José Alcamí
Journal:  Proteomics       Date:  2008-02       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.